NASDAQ: RLAY
Relay Therapeutics Inc Earnings Dates, Reports, Calls

Relay Therapeutics earnings were -$337.7M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest RLAY earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$76.0M, down 13.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, RLAY reported annual earnings of -$337.7M, with -1.2% growth. The next RLAY earnings date is Jun 3, 2025.

RLAY earnings history

Current Revenue
$10.0M
Current Earnings
-$337.7M
Current Profit Margin
-3,374.7%

RLAY Return on Equity

Current Company
-44.4%
Current Industry
-2%
Current Market
34.1%
RLAY's Return on Equity (-44.4%)... subscribe to Premium to read more.
High Return on Equity Performance

RLAY undefined

Current Company
-39.6%
Current Industry
-0.4%
RLAY is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when RLAY announces earnings.

RLAY undefined

Current Company
-41.16%
Current Industry
5.9%
RLAY's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

RLAY vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
RLAY-$332.24M-$337.71MN/A-$2.36
STOK-$97.18M-$88.98MN/A-$1.65
FTRE-$107.30M-$328.50MN/A-$3.67
CGEM-$166.96M-$168.06MN/A-$2.78
SAGE-$399.64M-$400.67MN/A-$6.59

RLAY earnings dates

Next earnings date
Jun 3, 2025

Relay Therapeutics Earnings Reports & History FAQ

What were Relay Therapeutics's earnings last quarter?

On RLAY's earnings call on Invalid Date, Relay Therapeutics (NASDAQ: RLAY) reported Q4 2024 earnings per share (EPS) of -$0.42, up 37.31% year over year. Total RLAY earnings for the quarter were -$76.00 million. In the same quarter last year, Relay Therapeutics's earnings per share (EPS) was -$0.67.

If you're new to stock investing, here's how to buy Relay Therapeutics stock.

When does Relay Therapeutics report earnings?

The next RLAY earnings call is Invalid Date. Add RLAY to your watchlist to be reminded of Relay Therapeutics's next earnings date.

Is Relay Therapeutics profitable or losing money?

As of the last Relay Therapeutics earnings report, Relay Therapeutics is currently losing money. Relay Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$337.71 million, a 1.25% decrease year over year.

What was RLAY's earnings growth in the past year?

As of Relay Therapeutics's earnings date in Invalid Date, Relay Therapeutics's earnings has grown year over year. RLAY earnings in the past year totalled -$337.71 million.

What are Relay Therapeutics's earnings expectations?

The current EPS estimate for Relay Therapeutics's earnings report in Invalid Date is -$0.71.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.